Los medicamentos biosimilares ante el espejo: ¿una solución en clave de equidad y de costes o el origen de próximos conflictos terapéuticos?
When term of protection available for patents on biological medicine is over, biosimilar medicinal products appear as an alternative. Regulation, suitability, safety, efficacy, equity and cost, represent some highlights.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=5635397 |
| Source: | DS : Derecho y salud, ISSN 1133-7400, Vol. 25, Nº. 1, 2015, pags. 149-157 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|